Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Collagen type III alpha 1 chain (COL3A1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA that encodes the alpha 1 chain of type III collagen, a fibrillar collagen essential for the structural integrity of extensible tissues like the skin, lungs, and vascular system (UniProt P02461). This 3'-UTR contains conserved binding sites for the miR-29 family of microRNAs, which act as potent repressors of collagen synthesis by promoting mRNA degradation and inhibiting translation (PMID: 18156152). In various fibrotic diseases, such as liver cirrhosis and pulmonary fibrosis, the downregulation of miR-29 leads to the pathological over-stabilization of COL3A1 mRNA and subsequent excessive collagen deposition (PMID: 21464369). Consequently, the COL3A1 mRNA 3'-UTR is a primary target for RNA-based therapeutics, including microRNA mimics like Remlarsen (MRG-201) and antisense oligonucleotides designed to reduce collagen production in fibrotic tissues (ClinicalTrials.gov NCT03601052). While targeting this region offers a promising anti-fibrotic strategy, it carries significant safety risks, as excessive suppression of COL3A1 can lead to vascular fragility and increased risk of organ rupture, mimicking the phenotype of vascular Ehlers-Danlos syndrome (PMID: 24607332). This target represents a sophisticated approach to managing extracellular matrix remodeling by intervening at the post-transcriptional level.
MicroRNA-mediated translational repression and mRNA decay
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen type III alpha 1 chain mRNA 3'-untranslated region (COL3A1 mRNA 3'-UTR) (COL3A1 mRNA 3'-UTR).